|Articles|March 18, 2021
Deloitte Releases 12th Annual Life Sciences Industry Accounting Guide
Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
Advertisement
On Mar. 16 Deloitte released its 12th annual Life Sciences Industry Accounting Guide. The report provides a comprehensive look at some of the complex issues that finance and accounting professionals in the life sciences industry face including R&D costs, acquisitions and divestitures, consolidation, contingencies, revenue recognition, income taxes, financial instruments, and financial statement presentation and disclosure.
Some of the main themes from this year’s edition include:
- COVID-19-Related Accounting and Financial Reporting Considerations for Life Sciences Entities
- IPOs and SPACs
- Revenue Recognition
- Structured Trade Payable Arrangement
For additional information and the full report, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5